Created at Source Raw Value Validated value
Oct. 7, 2021, 9:30 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group SOBERANA PLUS: 50 \u00b5g of RBD + adjuvant; 0.5 mL by intramuscular route. Treatment scheme: one dose. Presentation: Vial with single dose.;Immunogenicity; Vaccine ;Immunotherapy; Active ;Injections; Intramuscular;Single Dose;SOBERANA PLUS", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "50 \u03bcg of RBD + adjuvant, 0.5 mL;1;IM", "treatment_id": 513, "treatment_name": "Finlay-fr-1a anti-sars-cov-2 vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]